MSB 0.54% 92.5¢ mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-298

  1. 3,889 Posts.
    lightbulb Created with Sketch. 1320
    "everyone stayed home etc etc."

    Hmm, if the potential participants of the COVID-19 trial stayed home, they'd most likely be dead.

    The trial only accepts COVID-19 Critical patients, they are most likely intubated. To be more precise;

    https://hotcopper.com.au/data/attachments/2569/2569255-9be93b625ccbdb25e28b08ef0582566c.jpg

    Critically ill to the extent this is the last of the inclusion criteria;

    "The patient or his/her legally authorized representative (LAR) is able to provide informed consent"

    From https://clinicaltrials.gov/ct2/show/record/NCT04371393?term=mesoblast&draw=2
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
92.5¢
Change
0.005(0.54%)
Mkt cap ! $1.056B
Open High Low Value Volume
93.0¢ 93.5¢ 91.5¢ $1.473M 1.596M

Buyers (Bids)

No. Vol. Price($)
1 32370 92.5¢
 

Sellers (Offers)

Price($) Vol. No.
93.0¢ 60258 5
View Market Depth
Last trade - 16.10pm 17/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.